|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 79.92 EUR | +1.63% |
|
-6.59% | +18.72% |
| 08-05 | Argus Research Adjusts Ventas Price Target to $98 From $92 | MT |
| 08-04 | Citigroup Adjusts Price Target on Ventas to $110 From $100, Maintains Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Healthcare REITs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 171B | |||||
| 47.46B | |||||
| 15.02B | |||||
| 14.75B | |||||
| 10.7B |
- Stock Market
- Stocks
- VTR Stock
- VEN Stock
- Charts Ventas, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
